Anti-Cancer Drug Design

Prevention of adriamycin-induced mdrl gene amplification and expression in mouse leukemia cells by simultaneous treatment with the anti-recombinogen bromovinyldeoxyuridine
pp. 307-312(6)
Authors: Fahrig R.; Steinkamp-Zucht A.; Schaefer A.

Synthesis, DNA binding and cytotoxicity of isohelical DNA groove binding platinum complexes
pp. 313-322(10)
Authors: Wheate N.; Webster L.; Brodie C.; Grant Collins J.

Water-soluble organotellurium compounds inhibit thioredoxin reductase and the growth of human cancer cells
pp. 323-330(8)
Authors: Engman L.; Kanda T.; Gallegos A.; Williams R.; Powis G.

Role of crown-like side chains in the biological activity of substituted-phenoxazone drugs
pp. 331-338(8)
Authors: Karawajew L.; Glibin E.; Maleev V.; Czerwony G.; Dörken B.; Davies D.; Veselkov A.

Synthesis and cytotoxic activity of carboxamide derivatives of benzimidazo[2,1-a]isoquinoline and pyrido[3,2:4,5]imidazo[2,1-a]isoquinoline
pp. 339-346(8)
Authors: Deady L.; Rodemann T.; Finlay G.; Baguley B.; Denny W.

The abnormal cytotoxicities of 2,5-diaziridinyl-1,4-benzoquinone-3-phenyl esters
pp. 347-360(14)
Authors: Di Francesco A.; Hargreaves R.; Wallace T.; Mayalarp S.; Hazrati A.; Hartley J.; Butler J.

Antineoplastic agents 442. Synthesis and biological activities of dioxostatin
pp. 361-371(11)
Authors: Pettit G.; Lippert J.; Boyd M.; Verdier-Pinard P.; Hamel E.

Structural requirements for the formation of anthracycline-DNA adducts
pp. 373-386(14)
Authors: Cutts S.; Parker B.; Swift L.; Kimura K-i.; Phillips D.

Erratum. Synthesis and antimelanoma activity of analogues of N-acetyl-4-S-cysteaminylphenol
pp. 387-387(1)
Authors: Lant N.; McKeown P.; Kelland L.; Rogers P.; Robins D.